Ventilator-associated pneumonia (VAP) is the most important and common infection affecting patients ventilated with mechanical ventilators in intensive care units (ICU). VAP is defined as incubation-free pneumonia at 48-72 hours after endotracheal intubation. This retrospective study included adult patients (> 18 years old) who were hospitalized in our hospital’s General ICU between January 2018 and December 2019. According to the culture results, the patients were divided into two groups as VAP developing and non-VAP. The patients were evaluated in terms of causative agents, antibiotic susceptibilities and risk factors. Differences were reflected as significant at p
___
1. Rodrigues AN, Fragoso L, Beserra FdM, et al. Determining impacts and factors in ventilator-associated pneumonia bundle. Rev Bras Enferm. 2016;69:1045-51.
2. Othman AA, Abdelazim MS. Ventilator-associated pneumonia in adult intensive care unit prevalence and complications. Egypt J Crit Care Med. 2017;5:61-3.
3. Ardehali SH, Fatemi A, Rezaei SF, et al. The effects of open and closed suction methods on occurrence of ventilator associated pneumonia; a comparative study. Arch Acad Emerg Med. 2020;8:8.
4. Tan M, Zhu J-C, Du J, et al. Effects of probiotics on serum levels of Th1/Th2 cytokine and clinical outcomes in severe traumatic brain-injured patients: a prospective randomized pilot study. Critical care. 2011;15:290.
5. Mahmoodpoor A, Hamishehkar H, Asghari R, et al. Effect of a probiotic preparation on ventilator‐associated pneumonia in critically ill patients admitted to the intensive care unit: a prospective double‐blind randomized controlled trial. Nutr Clin Pract. 2019;34:156-62.
6. Kalil AC, Metersky ML, Klompas M, et al. Management of adults with hospitalacquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Cli Infect Dis. 2016;63:61-111.
7. Tagrikulu H, Memis D, Inal MT, ve ark. Yogun bakim hastalarinda ventilatör iliskili pnömoni insidansinin arastirilmasi/investigation of ventilator associated pneumoniae in intensive care patients. Turkish J Intensive Care. 2016;14:28.
8. Garner JS, Jarvis WR, Emori TG, et al. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988;16:128-40.
9. Shaker M, Saad-eldeen S, Helmy H, et al. Description of clinical and microbiological characteristics of ventilator associated pneumonia patients at surgical intensive care unit. ZUMJ. 2019;26:38-45.
10. Wolfensberger A, Meier M-T, Clack L, et al. Preventing ventilator-associated pneumonia—a mixed-method study to find behavioral leverage for better protocol adherence. Infect Cont Hosp Epidemiol. 2018;39:1222-9.
11. Zeng J, Wang C-T, Zhang F-S, et al. Effect of probiotics on the incidence of ventilator-associated pneumonia in critically ill patients: a randomized controlled multicenter trial. Intens Care Med. 2016;42:1018-28.
12. Şahin AR, Yıldız BT, Aktemur A, et al. Evaluation of nosocomial infections in a neurological intensive care unit of a university hospital. J Contemp Med Sci. 2019;9:43-7.
13. Stoclin A, Rotolo F, Hicheri Y, et al. Ventilator-associated pneumonia and bloodstream infections in intensive care unit cancer patients: a retrospective 12-year study on 3388 prospectively monitored patients. Support Care Cancer. 2020;28:193-200.
14. Papazian L, Klompas M, Luyt C-E. Ventilator-associated pneumonia in adults: a narrative review. Intens Care Med. 2020:1-19.
15. Chastre J, Fagon J-Y. Ventilator-associated pneumonia. Am J Respir Crit Care Med. 2002;165:867-903.
16. Forel J-M, Voillet F, Pulina D, et al. Ventilator-associated pneumonia and ICU mortality in severe ARDS patients ventilated according to a lung-protective strategy. Critical Care. 2012;16:65.
17. Legoff J, Zucman N, Lemiale V, et al. Clinical significance of upper airway virus detection in critically ill hematology patients. Am J Respir Crit Care Med. 2019;199:518-28.
18. Blot S, Koulenti D, Dimopoulos G, et al. Prevalence, risk factors, and mortality for ventilator-associated pneumonia in middle-aged, old, and very old critically ill patients. Critic Care Med. 2014;42:601-9.
19. Öcal N, Öcal R, Özer S, et al. Prognostic value of unchangeable risk factors for and the radiologic scoring system in ventilator-associated pneumonia. J Crit Intensive Care. 2016;7:44.
20. Bilici A, Karahocagil MK, Yapıcı K, et al. Ventilator associated pneumonia: incidence, risk factors, and causative agents. Van Med J. 2012;19:170-6.
21. Dananché C, Vanhems P, Machut A, et al. Trends of incidence and risk factors of ventilator-associated pneumonia in elderly patients admitted to French ICUs between 2007 and 2014. Critic Care Med. 2018;46:869-77.
22. Kundakci A, Ozkalaycı O, Zeyneloglu P, et al. Risk factors for ventilatorassociated pneumonia in a surgical ICU. Critical Care. 2013;17:139.
23. Babbar P, Biswal M, Digamber B, et al. Healthcare associated infections in intensive care units: a pilot study in a tertiary care public hospital in India. J Prevent Infect Cont. 2019;5:1.
24. Li Y, Liu C, Xiao W, et al. Incidence, risk factors, and outcomes of ventilatorassociated pneumonia traumatic brain injury: a meta-analysis. Neurocritical Care. 2019:1-14.
25. Yang X, Lai Y, Li C, et al. Molecular epidemiology of Pseudomonas aeruginosa isolated from lower respiratory tract of ICU patients. Brazilian J Biol. 2020 (AHEAD).
26. Rathod A, Soni S, Patel K, et al. Prevalence of various bacterial pathogens causing ventilator associated pneumonia (vap) isolated from icu in tertiary care hospital. Natl J Integr Res Med. 2017;8.
27. Karasu D, Yılmaz C, Durmuş G, et al. Evaluation of healthcare-associated infections in critically ill patients receiving long-term treatment in the intensive care unit. Klimik J. 2016;29:71-6.
28. Sağmak-Tartar A, Özer AB, Ulu R, et al. Microbiological evaluation of the pathogens isolated from the endotracheal aspirate samples of the patients followed in the intensive care units: a one-year retrospective analysis. Klimik J. 2018;31:56-60.